Advertisement

Latest News

8 Dermatology Headlines You Missed in November 2025

2 hours ago

This review of November 2025 highlights several notable news stories covered in the dermatology space.

Benefits of Oral BTKi Administration in CSU

3 hours ago

Jason Hawkes, MD, MS details the clinical advantages and patient populations best suited for oral BTK inhibitor therapy, such as remibrutinib, in CSU.

Personalizing CSU Management and the Role of Multidisciplinary Care

3 hours ago

Amanda Armstrong, MD, MPH, predicts a move toward mechanism-based therapy selection and highlights biomarkers that could guide personalized treatment.

Combination Therapies for IBD and Future Outlook

3 hours ago

A conclusion emphasizing the importance of translating clinical research into everyday practice and continuing innovation to improve patient quality of life and long-term outcomes.

Non-Cranial Symptoms in GCA

3 hours ago

Advertisement
Advertisement